CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
Isabel Rodríguez-GoncerMaria Ruiz-RuigomezFrancisco López-MedranoLaura CorbellaNatalia PolancoEsther González MonteRafael San-JuanTamara Ruiz-MerloPatricia ParraLola FolgueiraAmado AndrésJose María AguadoMario Fernández-RuizPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Our findings do not confirm the existence of a relevant impact of CMV infection or (val)ganciclovir therapy on the risk of post-transplant BKPyV events.